XML 30 R17.htm IDEA: XBRL DOCUMENT v3.25.1
PROPERTY, PLANT AND EQUIPMENT
 12 Months Ended
Mar. 29, 2025
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consisted of the following:
(In thousands)March 29, 2025March 30, 2024
Land$1,985 $4,130 
Building and building improvements105,079 124,338 
Plant equipment and machinery181,825 204,622 
Office equipment and information technology130,924 129,979 
Haemonetics equipment395,152 456,414 
Construction in progress22,229 39,694 
     Total837,194 959,177 
Less: accumulated depreciation(553,142)(647,815)
Property, plant and equipment, net$284,052 $311,362 

Depreciation expense was $60.0 million, $55.8 million and $51.2 million in fiscal 2025, 2024 and 2023, respectively.
In the fourth quarter of fiscal 2025, the Company completed the divestiture of its Whole Blood product line within its Blood Center business unit and all related assets and liabilities were sold. The property, plant and equipment related to the divestiture had a gross value of $40.8 million and a net carrying value of $7.8 million and has been removed from the Consolidated Balance Sheets.

In the first quarter of fiscal 2025, the Company received $19.9 million of cash upon the sale of a manufacturing facility and related assets that previously met held for sale criteria, which resulted in a gain of $14.1 million that was recorded in selling, general and administrative expenses on the Consolidated Statements of Income.